Elucidating a false-negative

Gene Rearrangement High-Throughput Nucleotide Sequencing Humans Immunoglobulin Heavy Chains / genetics In Situ Hybridization, Fluorescence Lymphoma, B-Cell / classification Male Middle Aged Neoplasm Grading Proto-Oncogene Proteins c-bcl-2 / genetics Proto-Oncogene Proteins c-myc / genetics
B-cell lymphoma

Journal

Cold Spring Harbor molecular case studies
ISSN: 2373-2873
Titre abrégé: Cold Spring Harb Mol Case Stud
Pays: United States
ID NLM: 101660017

Informations de publication

Date de publication:
06 2019
Historique:
received: 18 02 2019
accepted: 27 03 2019
entrez: 5 6 2019
pubmed: 5 6 2019
medline: 27 5 2020
Statut: epublish

Résumé

The identification of

Identifiants

DOI: 10.1101/mcs.a004077 PMID: 31160360 PMC: PMC6549546
pubmed: 31160360
pii: mcs.a004077
doi: 10.1101/mcs.a004077
pmc: PMC6549546
pii:
doi:

Substances chimiques

BCL2 protein, human 0
Immunoglobulin Heavy Chains 0
MYC protein, human 0
Proto-Oncogene Proteins c-bcl-2 0
Proto-Oncogene Proteins c-myc 0

Types de publication

Case Reports Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2019 Peterson et al.; Published by Cold Spring Harbor Laboratory Press.

Références

Histopathology. 2016 Jun;68(7):1090-8
pubmed: 26426741
Cancer Genet. 2018 Feb;221:1-18
pubmed: 29405991
Mod Pathol. 2012 Jan;25(1):145-56
pubmed: 22002575
Blood. 2012 Aug 23;120(8):1552-61
pubmed: 22665937
Haematologica. 2019 Jun;104(6):e248-e251
pubmed: 30523057
Genes Chromosomes Cancer. 2018 Sep;57(9):459-470
pubmed: 29726617
Cancer Genet Cytogenet. 2010 Apr 1;198(1):71-5
pubmed: 20303018
Histopathology. 2013 Sep;63(3):418-24
pubmed: 23795946
Am J Surg Pathol. 2015 Aug;39(8):1132-9
pubmed: 25828391
Am J Surg Pathol. 2010 Mar;34(3):327-40
pubmed: 20118770
Bioinformatics. 2014 Jun 1;30(11):1627-9
pubmed: 24526710
Blood. 2017 Jan 19;129(3):280-288
pubmed: 27821509

Auteurs

Jess F Peterson (JF)

Division of Laboratory Genetics and Genomics, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota 55905, USA.

Beth A Pitel (BA)

Division of Laboratory Genetics and Genomics, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota 55905, USA.

Stephanie A Smoley (SA)

Division of Laboratory Genetics and Genomics, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota 55905, USA.

George Vasmatzis (G)

Center for Individualized Medicine-Biomarker Discovery, Mayo Clinic, Rochester, Minnesota 55905, USA.

James B Smadbeck (JB)

Center for Individualized Medicine-Biomarker Discovery, Mayo Clinic, Rochester, Minnesota 55905, USA.

Patricia T Greipp (PT)

Division of Laboratory Genetics and Genomics, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota 55905, USA.

Rhett P Ketterling (RP)

Division of Laboratory Genetics and Genomics, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota 55905, USA.
Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota 55905, USA.

William R Macon (WR)

Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota 55905, USA.

Linda B Baughn (LB)

Division of Laboratory Genetics and Genomics, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota 55905, USA.

Articles similaires

Comprehensive comparative analysis and development of molecular markers for Lasianthus species based on complete chloroplast genome sequences.

Yue Zhang, Meifang Song, Deying Tang et al.
1.00
Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH

questionsmedicales.fr › Phénomènes génétiques › Réarrangement des gènes › Elucidating a false-negative
questionsmedicales.fr › Techniques d'investigation › Techniques génétiques › Analyse de séquence › Séquençage nucléotidique à haut débit › Elucidating a false-negative
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Elucidating a false-negative
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Globulines › Sérum-globulines › Immunoglobulines › Sous-unités des immunoglobulines › Chaines lourdes des immunoglobulines › Elucidating a false-negative
questionsmedicales.fr › Techniques d'investigation › Techniques génétiques › Hybridation in situ › Hybridation fluorescente in situ › Elucidating a false-negative
questionsmedicales.fr › Maladies du système immunitaire › Syndromes immunoprolifératifs › Syndromes lymphoprolifératifs › Lymphomes › Lymphome malin non hodgkinien › Lymphome B › Elucidating a false-negative
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Adulte d'âge moyen › Elucidating a false-negative
questionsmedicales.fr › Diagnostic › Pronostic › Grading des tumeurs › Elucidating a false-negative
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines tumorales › Protéines oncogènes › Protéines proto-oncogènes › Protéines proto-oncogènes c-bcl-2 › Elucidating a false-negative
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Facteurs de transcription › Facteurs de transcription à motif basique hélice-boucle-hélice › Protéines proto-oncogènes c-myc › Elucidating a false-negative